Cargando…
Anti‐SARS‐CoV‐2 spike immunoglobulin G and immunoglobulin M titers decline as interval from the second inactivated vaccine dose to the onset of illness is prolonged in breakthrough infection patients
BACKGROUND: Understanding of the early immune response in severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) breakthrough infections is limited. METHODS: Ninety‐eight patients with coronavirus disease 2019 (COVID‐19) breakthrough infections were divided into two groups, with intervals from...
Autores principales: | Xu, Chuan‐cai, He, Zhi‐song, Lei, Wei, Zhu, Jin‐zhou, Zhao, Da‐guo, Kong, Jin‐dan, Wei, Yao, Xu, Ying, Huang, Jian‐An |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113280/ https://www.ncbi.nlm.nih.gov/pubmed/36759335 http://dx.doi.org/10.1111/crj.13590 |
Ejemplares similares
-
Pneumococcal Antibody Titers: A Comparison of Patients Receiving Intravenous Immunoglobulin Versus Subcutaneous Immunoglobulin
por: Abghari, Pamella F., et al.
Publicado: (2017) -
Intrathecal Administration of High-Titer Cytomegalovirus Immunoglobulin for Cytomegalovirus Meningitis
por: Fujiwara, Shin-ichiro, et al.
Publicado: (2014) -
Therapeutic Immunoglobulin Selected for High Antibody Titer to RSV also Contains High Antibody Titers to Other Respiratory Viruses
por: Orange, Jordan S., et al.
Publicado: (2015) -
Pollen Allergy Screening with Allergen-Specific and Total
Immunoglobulin E Titers
por: Yokoi, Hidenori, et al.
Publicado: (2022) -
Anti-spike protein antibody titer at the time of breakthrough infection of SARS-CoV-2 omicron
por: Adachi, Eisuke, et al.
Publicado: (2022)